World Marine Biotechnology Industry

World Marine Biotechnology Industry

This report analyzes the worldwide markets for Marine Biotechnology in US$ Million. The Global market is further analyzed by the following Product Segments: Marine Biomaterials, Marine Bioactive Substances, and Others. The Major End-Use Applications analyzed are Industrial Products, Health Care/Biotechnology, Consumer Products, Public Services & Infrastructure, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 84 companies including many key and niche players such as -

Aker BioMarine AS
Aqua Bio Technology ASA
BASF SE
CP Kelco
Cyanotech Corp.



I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
By Product Segment I-3
Biomaterials I-3
Bioactive Substances I-3
Others I-3
By End-Use Application I-4
Industrial Products I-4
Health Care/Biotechnology I-4
Consumer Products I-4
Public Services and Infrastructure I-4
Others I-4


II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW II-1
A Quick Primer II-1
Marine Biotechnology: A Science to Address Global Challenges II-2
Current and Future Analysis II-3
Impact of Economic Uncertainty in Retrospect II-4
Noteworthy Trends & Issues II-5
Medical, Food and Cosmetic Sectors Garner Research Dollars II-5
Select Marine Bio-Products Commercially Available II-5
Health-Promoting Benefits of Marine Algal Proteins II-5
Sea Anemone Toxins: Opportunities for Pharma & Agricultural
Sectors II-6
Marine Worm: Potential Role in Medical Applications II-6
Coral Reefs Offer Abundant Opportunities II-7
Marine Microalgae: Promising Potential in Varied Industries II-7
Commercially Cultivated Marine Microalgae Species and their
Applications II-8
Major Applications of Marine Microalgae Biomass or their
Extracts II-8
Polysaccharides from Marine Microalgae Holds Tremendous
Potential II-9
Select Marine Microalgae Species Producing Polysaccharides II-9
Carotenoids of Marine Origin: Key Applications II-10
Major Commercially Available Carotenoids II-10
Rising Demand for HVAB's: Threat to Marine Biodiversity? II-11
Marine Ingredients for Bonding Applications: A Research Focus II-11
Biopharmaceutical Companies Shift towards Marine Natural
Products II-11
Technology Advancements Aid Research Activities II-12
Partnerships: Vital for Development of Marine Biotechnology
Research II-12
Megaprojects Hold Significance for Marine Biotechnology
Development II-14
Lack of R&D Investment in Marine Biotech: A Challenge II-14
Preserving Marine Ecology: A Prime Concern II-15

2. A REVIEW OF END-USE MARKETS/ APPLICATIONS II-16
Marine Biotechnology for Sustainable Production of Healthy
Food Products II-16
Table 1: World Population by Geographic Region (2000-2050)
(in Millions) (includes corresponding Graph/Chart) II-17

Table 2: Top 5 Seafood Consuming Nations Based on Per-Capita
Intake (2013) (includes corresponding Graph/Chart) II-18

Table 3: World Aquaculture Market (2012): Breakdown of
Production Volume by Region (in ‘000 Tonnes) (includes
corresponding Graph/Chart) II-18

Table 4: World Capture Fisheries and Aquaculture Market
(2013): Percentage Breakdown of Production Volume by Inland
and Marine Segments (includes corresponding Graph/Chart) II-19

Table 5: Global Aquaculture Market (2013): Percentage Share
Breakdown of Production Volume by Fish Type (includes
corresponding Graph/Chart) II-19
Marine Resources as Functional Food Ingredients II-21
Health Benefits of Few Marine-derived Functional Food
Ingredients II-22
Marine-Derived Nutraceuticals II-23
Major Marine Nutraceutical Products: A Glance II-23
Global Omega-3 Ingredients Market - A Review II-24
Table 6: World Omega-3 Dietary Supplements Market (2013):
Percentage Share Breakdown of Volume Sales by Geographic
Region - North America, Europe, Asia-Pacific, and Rest of
World (includes corresponding Graph/Chart) II-25
Marine Biotechnology for Energy Supply II-25
Feasibility of Using Algae for Biofuel Production II-26
Application of Marine Organisms in the Cosmetics Industry II-26
Marine Ingredients in Cosmetics Industry II-27
Focus Shifts to Sustainable Sourcing of Marine Ingredients in
Cosmetics Industry II-27
Marine Biotechnology for Industrial Processing II-28
Marine Microbial Enzymes II-29
Marine-Derived Biopolymers & Biomaterials II-30
Marine Micro & Macro Algae II-30
Chitin & Chitosan II-31
Marine Bacteria II-32
Bioceramics II-32
Extremozymes II-32
Marine Biotechnology for Protecting Marine Ecosystems II-33
Biofouling II-33
Detecting Marine Pathogenic Organisms II-33
Bioremediation of Marine Ecosystems II-34
Marine Coatings Market II-34
Marine-Derived Pharmaceuticals II-34
Brief History II-34
Major Marine Sources for Drugs II-35
Applications of Marine Products in Pharmaceutical Industry II-35
Invertebrates - Major Focus of Research II-36
Marine Flora - Largely Unexplored II-36
Research Focus Entrenched on Marine Drugs II-37
Marine Pharmaceutical Products - Development/Approval Status
(2014) II-38
Robust Clinical Pipeline to Support Growth II-39
Anti-Cancer Drugs Dominate Drug Development Pipeline II-40
Overview of Approved Anti-Tumor Drugs of Marine Origin II-40
PharmaMar: Undisputed Leader in Oncology Medicines of Marine
Origin II-41
Cardiovascular Marine Products II-41
Cardiovascular Marine Products by Marine Source II-41
An Overview of Select Cardiovascular Marine Products II-42
Key Challenges in Discovery of Marine-derived Drugs II-42
Marine Genetic Resources: Regulatory Framework II-43
The Convention on Biological Diversity (CBD) and the Nagoya
Protocol II-43
The United Nations Convention on the Law of the Sea II-44

3. R&D ACTIVITY IN MARINE BIOTECHNOLOGY - A REVIEW II-45
Overview II-45
R&D Initiatives, Funding Programs & Research Priorities for
Marine Biotechnology II-46
The United States II-46
Canada II-47
Japan II-47
Europe II-47
Turkey II-48
Asia II-48
Australia & New Zealand II-48
China II-49
India II-49
South Korea II-49
Southeast Asia II-49
Latin America II-50
Middle East & Africa II-50
International Efforts in Marine Biotechnology Research II-50
Major R&D Projects in Marine Biotechnology Space II-51
EU Embarks on Ground-Breaking Marine Plankton Project II-51
KIOST Augments Research on Marine Biotechnology II-51
EU Launches BlueGenics Research Project II-51
Smithsonian Tropical Research Institute to Launch Global
Marine Biodiversity Project II-52

4. MARINE BIOTECHNOLOGY - AN OVERVIEW II-53
Prelude II-53
Significance of Marine Biodiversity II-53
Marine Biotechnology: Definition II-54
Why are Marine Organisms Crucial? II-54
Sources of Marine Biotech Products II-55
Key Marine Sources and Products II-55
Select Marine-Derived Products II-56
Marine Sponges II-56
Marine Plants II-56
Protista II-56
Marine Bacteria II-57
Marine Fungi II-57
Types of Marine Biotech Products II-57
Marine Biomaterials II-57
Marine Adhesives II-57
Marine Bioactive Substances II-58
Enzymes II-58
Haloperoxidase Enzymes II-58
Thermostable DNA-Modifying Enzymes II-58
Other Marine Products and Processes II-59
Marine Biomass II-59
Marine Bio-Process II-59
Significant Bio-Processes and their Applications II-59
End-Use Analysis II-59
Foods II-60
Nutraceuticals II-61
Medicine II-61
Cosmetics II-61
Research Tools II-61
Processing Technologies II-62
New Energy Sources II-62
Agriculture II-62
Industrial II-62
Food Safety II-63
Environmental Management II-63
Bioremediation II-63
Marine Biosurfactants II-63
Select Biosurfactants Produced from Marine Microorganisms II-64
Aquaculture and Marine Biotechnology II-64
Industrial Applications II-64
Healthcare II-65
Select Marine Diterpenes and Their Biological Activity II-65
Bioprospecting II-66
Consumer Products II-66
Select Macroalgal Materials and Applications in Cosmetic
Industry II-67
Public Services and Infrastructure II-67
Others II-67
An Insight into Select Marine-Origin Products II-67
Agar II-67
Major Seaweeds Used for Extracting Agar and Agarose II-68
Alginate II-68
Astaxanthin II-69
Carrageenan II-69
Chitin and Chitosan II-70
Chitin II-70
Chitosan II-70
Select Industrial Applications of Chitosan II-70
Collagen II-71
Salmon Calcitonin II-71

5. KEY RESEARCH FINDINGS ON MARINE ORGANISMS II-72
New Research Finding Reveals the Role of Opisthobranchs in
Lignarenones Biosynthesis II-72
Norwegian Researchers Explore Potential of Tunicate as a
Source of Biofuel and Fish Feed II-72
Scientists Unearth Medicinal Properties of Marine Enzyme,
Bacillus Licheniformis II-73
Salmon Peptone for Producing High-Value Biotech Products II-73
Norwegian Researchers Study Potential of Farmed Salmon Waste
as Nutrients to Nourish Kelp and Mussel II-73
Researchers Study Effectiveness of Alginate Supplementation on
Weight Loss II-73
Lamellarins Can Stop Cancer Drug Resistance: New Finding on
Marine Natural Product II-74
Evaluation of DHA and EPA Concentration in Algal Species II-74
Study of Potential Applications of Delesseria Sanguinea II-75
Scientists Use Bacteria Occurring in Marine Waters to Develop
New Assays II-75

6. PRODUCT INTRODUCTIONS/INNOVATIONS II-76
BiotechMarine Develops Sea Shine II-76
Lipotec Launches Seacode™ II-76
Bluewave Marine Ingredients Launches AminoMarine™ Fish Protein
Powder II-76
Cyvex Nutrition Rolls Out Protomine™ Fish Protein Powder II-76
Lipotec Unveils Seacode Marine-based Anti-Ageing Ingredient II-76
Marie Veronique Organics Rolls Out Pacific Line of Anti-Aging
Products II-76
DSM Unveils DHA plus EPA™ Product II-76
Aqua Bio Technology Launches New Marine-Based Ingredients II-77
La Prairie Launches Lifestyle Collection II-77

7. RECENT INDUSTRY ACTIVITY II-78
Superba™ Krill Oil Receives Regulatory Approval in India II-78
GlycoMar Collaborates With Biopol II-78
Aker Biomarine Inks Licensing Agreement with Neptune II-78
Aker BioMarine Inks Distribution Agreement with BioMar II-78
HEMARINA Inks Deal with LFB Bio-Manufacturing II-78
Lallemand Takes Over Aquapharm II-78
BASF Acquires Pronova II-79
FMC Takes Over Epax II-79
Seppic Takes Over BiotechMarine II-79
Aqua Bio Technology Bags Contracts from Cosmetics Company II-79
CRBM and CNBE Ink Marine Biotechnology Agreement II-79
Olympic Seafood Enters into Long-Term Licensing Agreement with
Aker BioMarine II-79
Stemtech International Inks Agreement with Marinova II-79
ABT Bags Multi Million Contract from Restorsea for
Aquabeautine XL™ Ingredient II-79
Aquapharm Collaborates with c-LEcta II-80
Aqua Bio Technology Signs Agreement with Amway II-80
Aquapharm Enters into Partnership with Aqua Bio Technology II-80

8. FOCUS ON SELECT PLAYERS II-81
Aker BioMarine AS (Norway) II-81
Aqua Bio Technology ASA (Norway) II-81
BASF SE (Germany) II-81
CP Kelco (US) II-82
Cyanotech Corp. (US) II-82
Nutrex Hawaii (US) II-82
FMC Health and Nutrition (US) II-83
NovaMatrix (Norway) II-83
GlycoMar Ltd. (UK) II-83
Jazz Pharmaceuticals plc (Ireland) II-84
Lonza Group Ltd. (Switzerland) II-84
Marinova Pty Ltd (Australia) II-84
New England Biolabs Inc (US) II-85
oceanBASIS GmbH (Germany) II-85
PharmaMar S.A (Spain) II-85
PML Applications Ltd. (UK) II-86
Prolume Ltd (US) II-86
BioLume®, Inc. (US) II-86
Royal DSM N.V (Netherlands) II-87
Sea Run Holdings, Inc. (US) II-87
SEPPIC (France) II-87
Biotech Marine (France) II-88
Tequesta BioVentures (US) II-88

9. GLOBAL MARKET PERSPECTIVE II-89
Table 7: World Recent Past, Current & Future Analysis for
Marine Biotechnology by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific, and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2013 through 2020 (includes corresponding Graph/Chart) II-89

Table 8: World Historic Review for Marine Biotechnology by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific,
and Rest of World Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2006 through 2012
(includes corresponding Graph/Chart) II-90

Table 9: World 15-Year Perspective for Marine Biotechnology by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific, and Rest of World
Markets for Years 2006, 2014 & 2020 (includes corresponding
Graph/Chart) II-91

Table 10: World Recent Past, Current & Future Analysis for
Marine Biotechnology by Product Segment - Biomaterials,
Bioactive Substances, and Other Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2013
through 2020 (includes corresponding Graph/Chart) II-92

Table 11: World Historic Review for Marine Biotechnology by
Product Segment - Biomaterials, Bioactive Substances, and
Other Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2006 through 2012 (includes
corresponding Graph/Chart) II-93

Table 12: World 15-Year Perspective for Marine Biotechnology
by Product Segment - Percentage Breakdown of Dollar Sales for
Biomaterials, Bioactive Substances, and Other Markets for
Years 2006, 2014 & 2020 (includes corresponding Graph/Chart) II-94

Table 13: World Recent Past, Current & Future Analysis for
Marine Biotechnology by End-Use Application - Industrial
Products, Health Care/Biotechnology, Consumer Products, Public
Services & Infrastructure and Other Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2013 through 2020 (includes corresponding Graph/Chart) II-95

Table 14: World Historic Review for Marine Biotechnology by
End-Use Application - Industrial Products, Health
Care/Biotechnology, Consumer Products, Public Services &
Infrastructure and Other Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2006 through
2012 (includes corresponding Graph/Chart) II-96

Table 15: World 15-Year Perspective for Marine Biotechnology
by End-Use Application - Percentage Breakdown of Dollar Sales
for Industrial Products, Health Care/Biotechnology, Consumer
Products, Public Services & Infrastructure and Other Markets
for Years 2006, 2014 & 2020 (includes corresponding
Graph/Chart) II-97


III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
Overview III-1
Aquaculture Biotechnology III-1
Policy Framework to Offer Support for Marine Biotechnology III-1
Product Introductions/Innovations III-2
Strategic Corporate Developments III-2
Key Players III-3
B.Market Analytics III-6
Table 16: US Recent Past, Current & Future Analysis for
Marine Biotechnology Analyzed with Annual Sales Figures in
US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-6

Table 17: US Historic Review for Marine Biotechnology
Analyzed with Annual Sales Figures in US$ Million for Years
2006 through 2012 (includes corresponding Graph/Chart) III-7

2. CANADA III-8
A.Market Analysis III-8
Outlook III-8
Strategic Corporate Development III-8
B.Market Analytics III-9
Table 18: Canadian Recent Past, Current & Future Analysis
for Marine Biotechnology Analyzed with Annual Sales Figures
in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-9

Table 19: Canadian Historic Review for Marine Biotechnology
Analyzed with Annual Sales Figures in US$ Million for Years
2006 through 2012 (includes corresponding Graph/Chart) III-10

3. JAPAN III-11
A.Market Analysis III-11
Outlook III-11
B.Market Analytics III-11
Table 20: Japanese Recent Past, Current & Future Analysis
for Marine Biotechnology Analyzed with Annual Sales Figures
in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-11

Table 21: Japanese Historic Review for Marine Biotechnology
Analyzed with Annual Sales Figures in US$ Million for Years
2006 through 2012 (includes corresponding Graph/Chart) III-12

4. EUROPE III-13
A.Market Analysis III-13
Marine Biotechnology: Promising Opportunities for Europe III-13
A Nascent Yet Promising Market III-13
Marine and Algae Oils Market in Europe: An Overview III-14
Prospects for Blue Technology in Baltic Sea Region III-14
A Distinct Identity for Marine Biotechnology: The Way Forward III-15
Marine Drug Discovery: Need for Diversifying Research Focus III-15
Regulations Governing Marine Biotechnology in Europe III-15
A Glance at Key Documents & Events Focused on Marine
Biotechnology III-16
Initiatives for Marine Biotechnology Growth III-17
The European Commission Policies on Blue Technology (Marine
and Freshwater Biotechnology) III-18
Horizon 2020: Aiming for Faster Marketability of Innovations III-19
ERA-NET III-19
Focus on Select Regional Markets III-19
Belgium III-19
Denmark III-20
Germany III-20
North Germany Focuses on Maritime Resources III-20
Ireland III-20
Norway III-21
Overview III-21
Norway Leads in Bioprospecting Arctic Genetic Resources in
Nordic Countries III-21
Market Participants III-22
Industrial Applications III-22
Pharmaceuticals III-22
Norwegian Marine Biotechnology Companies III-22
Iceland III-24
Spain III-24
The United Kingdom III-24
Overview III-24
Role of Marine Algal Biomass in Energy Sector in UK III-25
Product Innovations/Introductions III-25
Strategic Corporate Developments III-26
Key Players III-28
B.Market Analytics III-32
Table 22: European Recent Past, Current & Future Analysis
for Marine Biotechnology Analyzed with Annual Sales Figures
in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-32

Table 23: European Historic Review for Marine Biotechnology
Analyzed with Annual Sales Figures in US$ Million for Years
2006 through 2012 (includes corresponding Graph/Chart) III-33

5. ASIA-PACIFIC III-34
A.Market Analysis III-34
Outlook III-34
Australia III-34
China III-34
India III-35
Marine Environment Offers Abundant Opportunities for R&D
Initiatives III-35
Biotechnology Market in India on a Growth Trajectory III-35
Seaweed: A Lucrative Marine Product III-36
Government Initiatives III-36
New Zealand III-37
South Korea III-37
Strategic Corporate Developments III-37
Marinova Pty Ltd (Australia) - A Key Player III-38
B.Market Analytics III-39
Table 24: Asia-Pacific Recent Past, Current & Future
Analysis for Marine Biotechnology Analyzed with Annual Sales
Figures in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-39

Table 25: Asia-Pacific Historic Review for Marine
Biotechnology Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-40

6. REST OF WORLD III-41
A.Market Analysis III-41
Outlook III-41
Latin America III-41
Brazil III-41
B.Market Analytics III-42
Table 26: Rest of World Recent Past, Current & Future
Analysis for Marine Biotechnology Analyzed with Annual Sales
Figures in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-42

Table 27: Rest of World Historic Review for Marine
Biotechnology Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-43


IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 84 (including Divisions/Subsidiaries - 89)

The United States (25)
Canada (1)
Japan (2)
Europe (44)
- France (4)
- Germany (4)
- The United Kingdom (4)
- Spain (2)
- Rest of Europe (30)
Asia-Pacific (Excluding Japan) (15)
Latin America (1)
Middle East (1)